Panda High Plains Hemp Gin Marks Final Stage Commissioning to Bring Largest Industrial Hemp Processing Facility in the Western Hemisphere Online
전체 맥락을 이해하기 위해서는 본문 보기를 권장합니다.
"Each piece of the Panda Hemp Gin production line, including the three miles of overhead pneumatic duct lines, refining, blending, mechanical cottonization, hurd bagging and storage, baling, and more, must be individually started, checked, balanced, and commissioned," says Panda Biotech Executive Vice President Scott Evans. "Currently, all equipment is individually being brought online to be officially placed in service."
이 뉴스는 기업·기관·단체가 뉴스와이어를 통해 배포한 보도자료입니다.
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
DALLAS -- Businesswire -- Panda Biotech announced today that building construction is complete and the official commissioning process to bring its Panda High Plains Hemp Gin™ (the “Panda Hemp Gin”) project online began in early Q4. The commissioning process marks the final stage before beginning commercial operations in Q1 2024 at the 500,000 square foot Wichita Falls, Texas facility. The Panda Hemp Gin will process 10 metric tons of industrial hemp per hour to produce textile-grade fiber, hurd, short-fiber hurd mix, and a nutrient-rich co-product that will be pelletized. The facility is expected to be the largest hemp decortication center in the Western Hemisphere and among the largest in the world.
“Each piece of the Panda Hemp Gin production line, including the three miles of overhead pneumatic duct lines, refining, blending, mechanical cottonization, hurd bagging and storage, baling, and more, must be individually started, checked, balanced, and commissioned,” says Panda Biotech Executive Vice President Scott Evans. “Currently, all equipment is individually being brought online to be officially placed in service.”
Using only renewable energy sources, the engineering and production process at the Panda Hemp Gin has been certified green by Mid-South Engineering Company, in accordance with the International Capital Market Association’s Green Bond Principles. Panda Biotech has also partnered with Oritain, a scientific traceability company, to bring the most traceable hemp grown 100 percent in the United States to market.
Additionally, Panda Biotech is actively signing contracts with producers to grow the hemp feedstock for the 2024 growing season, as well as purchasing hemp fiber that has already been harvested or processed. The company recently unveiled an unmatched pay-to-grow program for producers to begin growing Panda hemp. With up-front, guaranteed money and agronomy support, Panda producers also receive tested and proven seed at no cost, successfully mitigating the risk producers may assume and underscoring Panda’s commitment and promise to the farming community. The benefits of growing hemp are substantial, as it is an excellent rotational crop that remediates the soil and provides a competitive margin. For those interested in learning more, please visit the growers inquiry form found at pandabiotech.com.
ABOUT PANDA BIOTECH
Based in Dallas, Texas, privately-held Panda Biotech, LLC is a first-mover in the emerging U.S. industrial hemp fiber and hurd industry. Panda Biotech’s executive leadership has extensive experience developing, financing, constructing, and operating large-scale infrastructure facilities in clean energy. They have developed 22 projects representing approximately $12 billion in invested capital. The company is currently developing large-scale industrial hemp gin facilities. Panda’s first project, the Panda High Plains Hemp Gin™ LLC (Panda Hemp Gin), is in partnership with Aka-Ag, LLC, a wholly owned subsidiary of the Southern Ute Indian Tribe Growth Fund. The facility is located in Wichita Falls, TX. It will be the largest hemp processing facility in the Western Hemisphere. For more information, please visit www.pandabiotech.com and @pandabiotech on Instagram, Twitter, or LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231211826527/en/
이 뉴스는 기업·기관·단체가 뉴스와이어를 통해 배포한 보도자료입니다.
출처:Panda Biotech, LLC
보도자료 통신사 뉴스와이어(www.newswire.co.kr) 배포
Copyright © 뉴스와이어. 무단전재 및 재배포 금지.
- 인터넷신문 ‘AI기사 작성’ 특강… 챗GPT 기초에서 실전까지 - 뉴스와이어
- SBC 메디칼 그룹 홀딩스, 메디롬 헬스케어 테크놀로지스와 비즈니스 제휴 발표 - 뉴스와이어
- 에어게인, 최초의 통합 인공지능 AT-플라이트 애셋 추적 솔루션 출시 - 뉴스와이어
- 아로마티카, 국내 뷰티 업계 최초 ‘플라스틱 재생원료 100% 사용’ 승인 - 뉴스와이어
- GS리테일, 6개 스타트업과 혁신 시너지 낸다 - 뉴스와이어
- LG에너지솔루션, 미국 리비안에 차세대 원통형 ‘4695’ 배터리 공급 - 뉴스와이어
- 삼성바이오로직스, 규범준수경영·정보보호 2종 국제표준 획득 - 뉴스와이어
- LG화학, 미용필러 ‘와이솔루션’ 리더스 포럼 개최 - 뉴스와이어
- 더 넓은 무대로… 녹십자수의약품, 독일 유로티어 2024 참가 ‘세계시장 공략’ - 뉴스와이어
- 2024 청년 아트페어 ‘100그라운드’ 개최 - 뉴스와이어